Amylyx Pharmaceuticals Announces First Participant Dosed in

- Largest ever PSP clinical trial will evaluate the efficacy and safety of AMX0035 in adults with PSP compared to placebo


- Trial to enroll approximately 600 participants across the U.S., Canada,...

Related Keywords

United States , Canada , Massachusetts , Japan , Munich , Bayern , Germany , Cambridge , Cambridgeshire , United Kingdom , Lahar Mehta , Kristophe Diaz , Linkedin , Exchange Commission , Amylyx Pharmaceuticals Inc , Amylyx Pharmaceuticals , Head Of Global Clinical Development At Amylyx , Movement Disorder Society , Nasdaq , Department Of Neurology At , European Union , Twitter , Executive Director , Chief Science Officer , Progressive Supranuclear Palsy Rating Scale , Movement Disorder Society Unified Parkinson , Disease Rating Scale Part , Open Label Extension , Primary Investigator , Global Clinical Development , Private Securities Litigation Reform Act , Amylyx United States Securities , Amylyx Quarterly Report , Markets ,